recurrent small intestine cancer
Showing 1 - 25 of >10,000
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)
Not yet recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan hydrochloride liposome Injection
- Topotecan
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023
PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy
Not yet recruiting
- Small Intestine Disease
- +5 more
- (no location specified)
Jan 30, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 23, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)
Not yet recruiting
- Recurrent Extensive Stage Small Cell Lung Carcinoma
-
Hangzhou, China
- +2 more
Feb 5, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Chemotherapy
- +2 more
- (no location specified)
Jan 9, 2023
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Apr 21, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Adenosine A2B Receptor Antagonist PBF-1129
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 1, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Sep 7, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Not yet recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Biopsy
- +4 more
-
Los Angeles, California
- +8 more
Jan 31, 2023
Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,
Recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +7 more
- Auranofin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jun 27, 2022
NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)
Recruiting
- NSCLC (Non-small-cell Lung Cancer)
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 21, 2022
EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)
Recruiting
- EGFR Exon 20 Mutation
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)
Recruiting
- Extensive-stage Small Cell Lung Cancer
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 27, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- TQB3909 tablet
-
Zhengzhou, Henan, China
- +1 more
Jul 17, 2023
Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +5 more
- Atezolizumab
- Temozolomide
-
Indianapolis, Indiana
- +2 more
Oct 26, 2022